IRadimed Corporation
IRMD
$51.33
-$0.95-1.82%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 11.04% | 11.71% | 13.23% | 16.05% | 19.87% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.04% | 11.71% | 13.23% | 16.05% | 19.87% |
| Cost of Revenue | 9.39% | 9.66% | 8.63% | 11.48% | 23.50% |
| Gross Profit | 11.54% | 12.34% | 14.67% | 17.47% | 18.80% |
| SG&A Expenses | 15.46% | 15.71% | 18.20% | 15.76% | 14.87% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.93% | 12.63% | 14.00% | 12.99% | 17.54% |
| Operating Income | 9.01% | 9.63% | 11.47% | 23.53% | 25.46% |
| Income Before Tax | 10.36% | 11.67% | 13.74% | 26.97% | 29.54% |
| Income Tax Expenses | 10.27% | 10.91% | 12.45% | 27.05% | 26.50% |
| Earnings from Continuing Operations | 10.39% | 11.87% | 14.09% | 26.95% | 30.37% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 10.39% | 11.87% | 14.09% | 26.95% | 30.37% |
| EBIT | 9.01% | 9.63% | 11.47% | 23.53% | 25.46% |
| EBITDA | 8.56% | 9.53% | 11.56% | 21.45% | 20.99% |
| EPS Basic | 9.84% | 11.28% | 13.52% | 26.40% | 29.89% |
| Normalized Basic EPS | 9.77% | 11.03% | 13.28% | 26.54% | 29.19% |
| EPS Diluted | 9.82% | 10.28% | 12.85% | 25.60% | 29.31% |
| Normalized Diluted EPS | 9.83% | 11.16% | 13.30% | 26.32% | 28.73% |
| Average Basic Shares Outstanding | 0.50% | 0.53% | 0.50% | 0.44% | 0.38% |
| Average Diluted Shares Outstanding | 0.44% | 0.42% | 0.50% | 0.62% | 0.73% |
| Dividend Per Share | 326.67% | 213.33% | -- | -- | -- |
| Payout Ratio | -0.11% | -0.08% | -0.22% | -0.41% | -0.54% |